The Meril MeriLisa HIV 1-2 Gen 3 ELISA Kit – 96 Tests is a professional in-vitro diagnostic enzyme immunoassay designed for the qualitative detection of antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human serum or plasma.
This third-generation HIV ELISA is designed to detect multiple antibody classes, including IgM, IgG and IgA antibodies, helping professional laboratories perform HIV antibody screening using a standard ELISA workflow.
The MeriLisa HIV 1-2 Gen 3 kit is supplied in a 96-test laboratory format and is intended for appropriately trained laboratory, Blood banks and healthcare professionals.
Brand: Meril Diagnostics
Product Family: MeriLisa
Product Name: MeriLisa HIV 1-2 Gen 3 ELISA Kit
Manufacturer Product Code: HV3ELI-01
Category: Laboratory Reagents & Kits / Blood Bank Kits
Subcategory: ELISA / Infectious Disease Diagnostics
Test Type: HIV 1 & HIV 2 Antibody ELISA
Generation: 3rd Generation
Technology: Enzyme-Linked Immunosorbent Assay – ELISA
Assay Principle: Antibody Capture Sandwich ELISA
Detection: Anti-HIV-1 and Anti-HIV-2 antibodies
Antibody Classes Detected: IgM, IgG and IgA
HIV Antigens Used: Recombinant gp120, gp41 and gp36 antigens
Subtype Coverage: Includes HIV-1 subtype O and subtype C according to manufacturer information
Specimen Type: Human Serum / Plasma
Result Type: Qualitative – Reactive / Non-Reactive according to assay interpretation criteria
Pack Size: 96 Tests
Approximate Assay Time: 90 Minutes
Storage: 2–8°C refrigerated
Intended Use: Professional In-Vitro Diagnostic Use
Suitable Users: Diagnostic laboratories, hospitals, blood banks and appropriately trained laboratory professionals
Seller: Microsidd India
Location: RT Nagar, Bengaluru, Karnataka, India
MeriLisa HIV 1-2 Gen 3 is a third-generation HIV ELISA system used for qualitative detection of antibodies produced against HIV-1 and HIV-2.
Unlike a fourth-generation HIV assay, which may detect both HIV antibodies and p24 antigen, this third-generation product is an antibody-detection assay.
The use of a third-generation assay enables detection of different HIV antibody classes, including IgM, IgG and IgA, which is an important distinction from older antibody-only assay formats.
The assay uses recombinant HIV antigens including:
These antigens are used within the ELISA system to detect antibodies directed against HIV-1 and HIV-2.
The MeriLisa HIV 1-2 Gen 3 kit is intended to detect:
Antibodies against HIV-1
and
Antibodies against HIV-2
The manufacturer also identifies detection of HIV-1 subtype O and subtype C within the assay's stated coverage.
This kit does not represent an HIV p24 antigen test and should not be described as a fourth-generation antigen-antibody assay.
The assay uses a third-generation ELISA format designed to detect multiple HIV antibody classes.
Designed for professional qualitative testing for antibodies against both major HIV types.
Detection of multiple antibody classes distinguishes this assay from earlier-generation antibody tests.
The assay incorporates recombinant HIV antigens including gp120, gp41 and gp36.
Manufacturer information states detection of HIV-1 subtype O and C in addition to standard HIV-1/HIV-2 antibody detection.
Designed for batch testing in professional ELISA laboratories.
Manufacturer literature lists an approximate assay time of 90 minutes.
Designed for use with appropriate ELISA microplate processing, washing and reading equipment according to the current manufacturer's IFU.
This is not a home HIV self-test or rapid card test.
According to the manufacturer's stated evaluation data:
| Parameter | Manufacturer-Stated Performance |
|---|---|
| Diagnostic Sensitivity | 100% |
| Diagnostic Specificity | >99.5% |
| Assay Time | Approx. 90 Minutes |
| Pack Format | 96 Tests |
| Generation | 3rd Generation |
| HIV Types | HIV-1 & HIV-2 |
| Antibody Classes | IgM, IgG & IgA |
Performance figures apply to the manufacturer's stated evaluation conditions and should not be interpreted as a guarantee for every specimen or laboratory environment.
The 96-test ELISA configuration provides several practical benefits for professional laboratories.
It allows multiple patient samples to be processed within a controlled ELISA workflow, making it useful for laboratories performing regular HIV antibody screening.
The third-generation format detects multiple antibody classes and uses recombinant HIV antigens, while the plate-based format is suitable for laboratories already equipped with compatible ELISA readers, washers and associated laboratory equipment.
The larger batch format may also be more practical than individual rapid tests for laboratories processing multiple specimens together.
The MeriLisa HIV 1-2 Gen 3 ELISA Kit is intended for trained professional users, including:
This product is not intended for unsupervised home testing or consumer self-testing.
The MeriLisa HIV ELISA may be incorporated into professional laboratory workflows for:
The kit should always be used according to the current manufacturer IFU and applicable national/institutional testing protocol.
MeriLisa HIV 1-2 Gen 3 uses an ELISA-based antigen-antibody reaction.
Recombinant HIV antigens are incorporated into the test system.
If antibodies against HIV-1 or HIV-2 are present in the patient's serum or plasma, they bind to the relevant HIV antigens during the assay.
Subsequent enzyme-linked reaction steps produce a measurable colour signal.
The optical density is measured using a compatible ELISA microplate reader, and results are interpreted using the manufacturer's prescribed cut-off calculation and assay validity criteria.
Exact sample volumes, incubation conditions, wash cycles, wavelength, cut-off calculations and control requirements should be taken from the current Meril Instructions for Use, not from a generic online protocol.
| Specification | Details |
|---|---|
| Brand | Meril Diagnostics |
| Product | MeriLisa HIV 1-2 Gen 3 |
| Product Code | HV3ELI-01 |
| Category | HIV ELISA Kit |
| Generation | Third Generation |
| Technique | ELISA |
| Principle | Antibody Capture Sandwich Assay |
| Detection | HIV-1 & HIV-2 Antibodies |
| Antibody Classes | IgM, IgG & IgA |
| Relevant Antigens | gp120, gp41, gp36 |
| Specimens | Human Serum / Plasma |
| Result | Qualitative |
| Pack Size | 96 Tests |
| Assay Time | Approx. 90 Minutes |
| Storage | 2–8°C |
| Use | Professional IVD |
| Feature | MeriLisa HIV 1-2 Gen 3 | HIV 4th Generation ELISA |
|---|---|---|
| HIV-1 Antibody | Yes | Yes |
| HIV-2 Antibody | Yes | Yes |
| IgM Detection | Yes | Yes |
| IgG Detection | Yes | Yes |
| p24 Antigen Detection | No | Yes |
| Test Type | Antibody ELISA | Antigen + Antibody ELISA |
| Laboratory Format | ELISA | ELISA |
This distinction is important when laboratories select the correct HIV assay.
A third-generation kit should not be represented as a p24 antigen test.
Pack Size: 96 Tests
A 96-test ELISA kit is supplied in a microplate-based laboratory format.
The term 96 tests refers to the manufacturer's kit configuration. The actual number of patient specimens that can be processed in a run may be lower because wells are also required for positive controls, negative controls, blanks or other assay requirements.
Laboratories should therefore calculate usable patient capacity according to the manufacturer's plate layout and their validated SOP.
The MeriLisa HIV ELISA assay is intended for use within a suitably equipped ELISA laboratory.
Depending on the validated laboratory workflow, equipment may include:
Specific reader wavelength and operating parameters must follow the current kit IFU.
Store the MeriLisa HIV 1-2 Gen 3 kit under refrigerated conditions at 2–8°C.
For proper reagent handling:
The manufacturer's current pack label and Instructions for Use always take precedence over general website information.
For professional laboratory supply:
For urgent institutional requirements, customers should confirm dispatch and transport arrangements before ordering.
A reactive HIV screening result should not be interpreted in isolation as a final HIV diagnosis.
HIV testing must be performed according to the applicable testing algorithm, using appropriate repeat or supplemental testing where required.
Laboratories should follow:
Clinical decisions should only be made by appropriately qualified healthcare professionals.
Browse professional ELISA kits for HIV, HCV, HBsAg, Dengue and other laboratory parameters:
https://microsidd.com/collections/elisa-range
Browse a wider range of professional laboratory reagents:
https://microsidd.com/collections/chemicals-liquids
As we optimise the remaining ELISA products, I recommend creating direct internal links between:
MeriLisa HIV → MeriLisa HCV → MeriLisa HBsAg → HIV 4th Generation ELISA → ELISA Range
This will create a much stronger infectious-disease ELISA topic cluster for Google and AI systems.
Microsidd India supplies professional diagnostic products, laboratory reagents and medical consumables from Bengaluru to healthcare and laboratory customers across serviceable locations in India.
Benefits of ordering from Microsidd include:
✓ Professional laboratory-focused product catalogue
✓ HIV, HCV, HBsAg and other ELISA products available
✓ Clear identification of assay generation and pack size
✓ Technical product information before purchase
✓ Related ELISA and laboratory products available
✓ GST invoice where applicable
✓ Bengaluru-based customer support
✓ Supply to serviceable locations across India
✓ Institutional and laboratory requirements supported subject to stock
✓ Temperature-sensitive reagent handling considerations clearly communicated
Microsidd India supplies professional HIV ELISA kits in Bengaluru as part of its laboratory diagnostics range.
Laboratories searching for:
HIV ELISA kit Bangalore
HIV 1 2 ELISA kit Bengaluru
MeriLisa HIV kit Bangalore
96 test HIV ELISA kit
HIV laboratory reagent near me
can order through Microsidd.com subject to availability, professional-use requirements and serviceability.
This local section is sufficient for local SEO; there is no need to repeatedly insert Bangalore/Bengaluru throughout the description.
Business Name: Microsidd India
Address: #09, Green Chambers, 14th Cross, RT Nagar, Bengaluru – 560032, Karnataka, India
Phone / WhatsApp: +91 63667 72288
Email: support@microsidd.com
Website: https://microsidd.com
Working Hours: Monday to Saturday, 10:00 AM – 6:00 PM IST
Watch product explainers, laboratory-product information, diagnostic guides and healthcare videos.
Subscribe here:
https://www.youtube.com/channel/UCun9gCID17Z5kK65W6JtIdg?sub_confirmation=1
Get updates about new products, laboratory supplies, offers and useful diagnostic-product information.
Join the Microsidd WhatsApp Channel:
https://whatsapp.com/channel/0029Va5lCoi1nozBZBL1gx3P
MeriLisa HIV 1-2 Gen 3 is a professional third-generation ELISA kit for qualitative detection of antibodies against HIV-1 and HIV-2 in human serum or plasma.
The 96-test configuration is HV3ELI-01.
The kit is supplied in a 96-test format.
Yes. This product is a third-generation HIV antibody ELISA.
Yes. It is designed to detect antibodies against both HIV-1 and HIV-2.
The manufacturer describes detection of IgM, IgG and IgA antibodies against HIV-1 and HIV-2.
No. MeriLisa HIV 1-2 Gen 3 is an antibody assay.
A fourth-generation HIV ELISA is required when the test system is designed for combined HIV antibody and p24 antigen detection.
Manufacturer information identifies recombinant gp120 and gp41 for HIV-1 and gp36 for HIV-2.
Yes. Manufacturer information identifies coverage of subtype O.
Yes. Manufacturer information also identifies subtype C detection.
The assay is intended for human serum or plasma according to the current manufacturer IFU.
Manufacturer information lists approximately 90 minutes.
The manufacturer reports 100% diagnostic sensitivity under its stated evaluation conditions.
The manufacturer reports greater than 99.5% diagnostic specificity under its stated evaluation conditions.
Not necessarily.
Some wells are normally required for controls, blanks or assay-validity requirements, so actual patient-sample capacity depends on the validated plate layout.
No. This is a professional ELISA laboratory kit.
A compatible ELISA microplate-reading system and other laboratory equipment are required according to the manufacturer's assay protocol.
It may be incorporated into professional HIV screening workflows where permitted by applicable blood-bank protocols, manufacturer intended use and regulatory requirements.
No.
A reactive screening result must be managed according to the applicable HIV testing algorithm and laboratory protocol. A single reactive screening assay should not independently be treated as a final diagnosis.
Store at 2–8°C refrigerated, following the conditions stated on the current supplied pack.
Because refrigerated storage is required, transportation should maintain suitable temperature conditions consistent with the product's labelled requirements.
Avoid freezing unless the current manufacturer Instructions for Use specifically permit it.
No.
MeriLisa is a laboratory ELISA system. Rapid HIV cards use a different test format and workflow.
Browse the Microsidd ELISA collection:
https://microsidd.com/collections/elisa-range
https://microsidd.com/collections/blood-bank-range
This product is non-returnable and non-exchangeable.
Please verify the brand, test generation, test parameter, methodology, specimen requirement, laboratory-equipment compatibility, pack size, storage requirement and product specifications before placing your order.
For laboratory reagents, customers should specifically verify the test parameter, methodology, analyser or equipment compatibility, reagent configuration and pack size before ordering.
Genuine cases involving an incorrect product received will be handled separately according to Microsidd.com's applicable policies and applicable law.
An original, continuous, unedited and uncut unboxing video is compulsory for making any claim regarding an incorrect product received.
The Meril MeriLisa HIV 1-2 Gen 3 ELISA Kit is intended for professional in-vitro diagnostic use only.
Testing must be performed by appropriately trained laboratory personnel according to the manufacturer's current Instructions for Use, laboratory SOPs, quality-control procedures and applicable national or institutional HIV testing guidelines.
A reactive HIV screening result is not, by itself, a final diagnosis. Reactive or discordant results must be handled according to the applicable HIV testing algorithm and interpreted by qualified healthcare professionals.
The product is not intended for unsupervised home testing, self-diagnosis or self-treatment
| Specification name | Specification Value |
|---|---|
| Detection technology | ELISA |
| Hiv test generation | 3rd generation |
| Product certifications & standards | CDSCO, ISO |
| Test method | Elisa |
| Test sample | Blood |
